Focus. Together. For patients and society.
Ipsen Way of Being
Guided by patient outcomes
WHO WE ARE
Ipsen is a global biopharmaceutical company, improving patients’ lives through research and innovation in oncology, rare disease & neuroscience.
WHAT WE DO
‘Improving people’s lives and health outcomes by focusing on areas of high unmet medical need, we are accelerating our momentum and rapidly boosting our pipeline to bring the full potential of our innovative medicines to patients.
Our strategy has been instrumental in making us a leader in our field. Our global presence, resources, expertise and strong track record commercialising our medicines are resulting in a real impact for people living with high unmet medical needs. We’re leveraging the full force of Ipsen’s infrastructure, innovation and passion to develop new therapies and valuable collaborations.
How Ipsen helps
Ipsen focuses on three key therapeutic areas, leveraging all our resources to help patients with unmet medical needs.
Oncology
We focus on improving the health outcomes of people living with cancer. With more than 35 years of oncology experience, we are driven by a strong sense of purpose: to support patients’ lives, improve health outcomes and create a positive impact for patient
Rare Disease
Pioneering rare disease treatments – Ipsen Ninety-four percent of rare medical conditions still have no treatment. Today our Rare Disease teams are more committed than ever to changing that. We leverage scientific expertise, our global presence, and a rob
Neuroscience
Ipsen is a global leader in neuroscience and toxins research for neurolomuscular treatments. Neuroscience is advancing at an unprecedented rate, and we are proud to be at the forefrontof this transformation. Our focus is on enabling children and adults
